Endothelial dysfunction in diabetes
Open accessThe DOI matches its Crossref record; 114 of the 115 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Endothelial dysfunction plays a key role in the pathogenesis of diabetic vascular disease. The endothelium controls the tone of the underlying vascular smooth muscle through the production of vasodilator mediators. The endothelium‐derived relaxing factors (EDRF) comprise nitric oxide (NO), prostacyclin, and a still elusive endothelium‐derived hyperpolarizing factor (EDHF). Impaired endothelium‐dependent vasodilation has been demonstrated in various vascular beds of different animal models of diabetes and in humans with type 1 and 2 diabetes. Several mechanisms of endothelial dysfunction have been reported, including impaired signal transduction or substrate availibility, impaired release of EDRF, increased destruction of EDRF, enhanced release of endothelium‐derived constricting factors and decreased sensitivity of the vascular smooth muscle to EDRF. The principal mediators of hyperglycaemia‐induced endothelial dysfunction may be activation of protein kinase C, increased activity of the polyol pathway, non‐enzymatic glycation and oxidative stress. Correction of these pathways, as well as administration of ACE inhibitors and folate, has been shown to improve endothelium‐dependent vasodilation in diabetes. Since the mechanisms of endothelial dysfunction appear to differ according to the diabetic model and the vascular bed under study, it is important to select clinically relevant models for future research of endothelial dysfunction. British Journal of Pharmacology (2000) 130 , 963–974; doi: 10.1038/sj.bjp.0703393
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both hyperglycemia and hyperinsulinemia alter the endothelium,27 disrupting the normal atheroprotective nitric oxide regulatory environment and encouraging a generalized proinflammatory, vasoconstrictive state predisposing to atherothrombosis.27–29”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [28]
Experimental — accuracy not yet measuredIn the citing paper
“Impaired endothelium-dependent vasodilation has been demonstrated in various vascular beds of animal models of diabetes and humans with type 1 and type 2 diabetes (80).”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [80]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
Baynes, J. W., & Thorpe, S. R. (1999) · Diabetes · doi:10.2337/diabetes.48.1.1 · Cited by 2,441 · cited 1×
“Although AGE formation occurs during the normal ageing process, it is markedly accelerated during diabetes, as a consequence of an increase in substrate, e.g. glucose, and in the prevailing oxidant stress in this disease (Baynes & Thorpe, 1999).”
BackgroundEndothelium‐derived relaxing and contracting factors
Furchgott, R. F., & Vanhoutte, P. M. (1989) · The FASEB Journal · doi:10.1096/fasebj.3.9.2545495 · Cited by 1,993
Self-citationOxidative Stress and Diabetic Vascular Complications
Giugliano, D., Ceriello, A., & Paolisso, G. (1996) · Diabetes Care · doi:10.2337/diacare.19.3.257 · Cited by 1,930
(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534
Protein kinase C activation and the development of diabetic complications.
Koya, D., & King, G. L. (1998) · Diabetes · doi:10.2337/diabetes.47.6.859 · Cited by 1,330
Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y. S., Pinsky, D., & Stern, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36966-1 · Cited by 1,306
Wolff, S. P., & Dean, R. T. (1987) · Biochemical Journal · doi:10.1042/bj2450243 · Cited by 1,271
Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor
Rubanyi, G. M., & Vanhoutte, P. M. (1986) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1986.250.5.h822 · Cited by 1,188
Self-citationBucala, R., Tracey, K. J., & Cerami, A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115014 · Cited by 1,165
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.
Johnstone, M. T., Creager, S. J., Scales, K. M., Cusco, J. A., Lee, B. K., & Creager, M. A. (1993) · Circulation · doi:10.1161/01.cir.88.6.2510 · Cited by 1,124
Research works printed but not linked: 6
- DE VRIESE A., 1999, Impaired endothelium‐derived hyperpolarizing factormediated renal vasodilatory response in diabetes: restoration with folate, J. Am. Soc. Nephrol., 10, 394A
- FRIEDMAN E.A., 1999, Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications, Diabetes Care, 22, B65
- FULTON D., 1996, Cytochrome P450 arachidonate metabolites: deficit in diabetes mellitus, FASEB J., 9, A113
- QUILLEY J., 1996, NO‐independent coronary vasodilation to bradykinin in diabetes, Hypertension, 28, P178
- 10.2337/diabetes.42.9.1246 · doi:10.2337/diabetes.42.9.1246
- 10.1042/cs19980382 · doi:10.1042/cs19980382
Cited by
Items 201–300 of 1,000
Rodríguez‐Mañas, L., Angulo, J., VALLEJO, S., Peiró, C., Sánchez‐Ferrer, A., Cercas, E., Bonnardeaux, P. L.-D., & Sánchez‐Ferrer, C. F. (2003) · Diabetologia · doi:10.1007/s00125-003-1056-1 · Cited by 80
“Aldose reductase, protein kinase C, endothelin receptors, and poly(ADP-ribose) polymerase are among the mechanisms suggested [25, 26, 27, 28].”
BackgroundEffect of fenofibrate on brachial artery flow-mediated dilatation in type 2 diabetes mellitus
Playford, D. A., Watts, G. F., Best, J. D., & Burke, V. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02847-3 · Cited by 80
Stress-induced RNA–chromatin interactions promote endothelial dysfunction
Calandrelli, R., Xu, L., Luo, Y., Wu, W., Fan, X., Nguyen, T. C., Chen, C.-J., Sriram, K., Tang, X., Burns, A. B., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18957-w · Cited by 79
Matsumoto, T., Noguchi, E., Kobayashi, T., & Kamata, K. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.12.028 · Cited by 79
“A considerable body of evidence now suggests that the impairment of endothelium-dependent relaxation seen in diabetes involves inactivation of NO by superoxide [5,6,10,22].”
BackgroundMethodInfluentialAspirin and clopidogrel: efficacy and resistance in diabetes mellitus
Angiolillo, D. J., & Suryadevara, S. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.12.001 · Cited by 79
El‐Remessy, A. B., Tawfik, H. E., Matragoon, S., Pillai, B. A., Caldwell, R. B., & Caldwell, R. W. (2010) · Experimental Diabetes Research · doi:10.1155/2010/247861 · Cited by 79
Ellis, A., Pannirselvam, M., Anderson, T. J., & Triggle, C. R. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705549 · Cited by 72
“Oxidative stress is a common characteristic of diabetes (De Vriese et al., 2000), and studies from our laboratory have demonstrated that elevated production of ROS contributes to endothelial dysfunction in the leptin-receptor-deficient, type II diabetic mouse db/db (Pannirselvam et al., 2002).”
BackgroundPATHOPHYSIOLOGY OF HYPERTENSION AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH DIABETES MELLITUS
Taylor, A. A. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70223-1 · Cited by 79
Matsumoto, T., Goulopoulou, S., Taguchi, K., Tostes, R. C., & Kobayashi, T. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13205 · Cited by 78
“EDRF production, bioavailability and signalling in smooth muscle cells (SMCs) are decreased in vessels under diabetic and hypertensive conditions (Kamata et al., 1989; De Vriese et al., 2000; Vanhoutte et al., 2005; 2009; Vanhoutte and Tang, 2008; Ding and Triggle, 2010).”
BackgroundInfluentialMakino, A., Platoshyn, O., Suárez, J., Yuan, J. X. ‐., & DILLMANN, W. H. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00433.2007 · Cited by 78
Cortigiani, L., Rigo, F., Gherardi, S., Galderisi, M., Bovenzi, F., & Sicari, R. (2014) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2014.02.010 · Cited by 78
Coronary endothelial dysfunction and mitochondrial reactive oxygen species in type 2 diabetic mice
Cho, Y.-E., Basu, A., Dai, A., Heldak, M., & Makino, A. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00234.2013 · Cited by 76
Dogné, S., Rath, G., Jouret, F., Caron, N., Dessy, C., & Flamion, B. (2016) · Diabetes · doi:10.2337/db15-1662 · Cited by 78
“Alteration in ACh-dependent vasorelaxation is another reliable marker of endothelial dysfunction, at least in rat models of type 1 and type 2 diabetes (26).”
BackgroundSartoretto, J. L., de Melo, G. D. A. N., de Carvalho, M. H. C., Nigro, D., Tostes, R. C., Scavone, C., Cuman, R. K. N., & Fortes, Z. B. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.022 · Cited by 78
Oxidant Stress, Immune Dysregulation, and Vascular Function in Type I Diabetes
Nicolls, M. R., HASKINS, K. M., & Flores, S. C. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1631 · Cited by 78
“Regardless of whether they are spontaneous or induced, a universal finding in a variety of diabetes models is impairment of endothelium-dependent relaxation (27, 57, 62, 78, 81).”
Muscle blood flow–O2 uptake interaction and their relation to on-exercise dynamics of O2 exchange
Ferreira, L. F., Poole, D. C., & Barstow, T. J. (2005) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2005.02.002 · Cited by 78
Maia, A. R., Batista, T. M., Victorio, J. A., Clerici, S. P., Delbin, M. A., Carneiro, E. M., & Davel, A. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105851 · Cited by 77
“Increased superoxide anion production in vascular tissue is associated with reduced endothelium-dependent relaxation in several models of cardiovascular diseases [25,26].”
BackgroundRacasan, S., Braam, B. G., Koomans, H. A., & Joles, J. A. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00314.2004 · Cited by 77
Metabolic Syndrome and Cardiometabolic Risk Factors
Papakonstantinou, E., Lambadiari, V., Dimitriadis, G., & Zampelas, A. (2014) · Current Vascular Pharmacology · doi:10.2174/15701611113116660176 · Cited by 68
Type 2 diabetes, cardiovascular risk, and the link to insulin resistance
STOLAR, M. W., & CHILTON, R. J. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80240-0 · Cited by 77
Tan, M., Liu, Y., Xu, Y., Yan, G., Zhou, N., Chen, H., Jiang, Z., & Peng, L. (2024) · Biomaterials Research · doi:10.34133/bmr.0035 · Cited by 76
“[1,2], where the disordered glucose metabolism and the resulting oxidative stress injury in hyperglycemia are key inducers [3,4].”
BackgroundKellogg, A. P., & Pop‐Busui, R. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.1521 · Cited by 76
“…available. secondary to enhanced aldose reductase (AR) activity, impaired nitric oxide synthesis (8, 12, 13, 15, 42), and endothelial dysfunction (19, 33) have all been identified as critical Additional studies ) activity with subsequent perturbations in prostaglandin (PG) metabolism (9, 12, 38,…”
Shi, Y., Ku, D. D., Man, R. Y. K., & Vanhoutte, P. M. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.099739 · Cited by 76
“In the carotid artery, L-arginine restored the blunted relaxations to normal, confirming that diabetes reduces the bioavailability of nitric oxide (De Vriese et al., 2000).”
BackgroundSelf-citationChaves, O. S., Teles, Y. C. F., Monteiro, M. M. D. O., Mendes, L. D. G., Agra, M. F., Braga, V. A., Silva, T. M. S., & Souza, M. (2017) · Molecules · doi:10.3390/molecules22010094 · Cited by 76
“, angiotensin II, endothelin, vasoconstrictors prostanoids, and reactive oxygen species, such as superoxide anion [21,22].”
BackgroundMehrabani, M., Najafi, M., Kamarul, T., Mansouri, K., Iranpour, M., Nematollahi, M. H., Ghazi‐Khansari, M., & Sharifi, A. M. (2015) · Cell Proliferation · doi:10.1111/cpr.12209 · Cited by 75
Guimarães, M. F. B. D. R., Brandão, A. H. F., Rezende, C. A. D. L., Cabral, A. C. V., Brum, A. P., Leite, H. V., & Capuruço, C. A. (2014) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-014-3220-x · Cited by 75
Tang, Y., Vater, C., Jacobi, A., Liebers, C., Zou, X., & Stiehler, M. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12611 · Cited by 74
“Furthermore, reduced tissue levels of EPCs and functional impairment of endothelium are often observed in patients with diabetes and cardiovascular disease (De Vriese et al., 2000; Vasa et al., 2001).”
BackgroundContractile apparatus dysfunction early in the pathophysiology of diabetic cardiomyopathy
Waddingham, M. T. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i7.943 · Cited by 66
Kanie, N., Matsumoto, T., Kobayashi, T., & Kamata, K. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705414 · Cited by 74
“…plays a key role in the pathogenesis of diabetic vascular disease (Kamata et al., 1989; Taylor et al., 1992; Tesfamariam & Cohen, 1992; Nitenberg et al., 1993; Pieper & Peltier, 1995; Poston & Taylor, 1995; Williams et al., 1996; Koltai et al., 1997; Pieper, 1998; De Vriese et al., 2000).”
BackgroundDiabetes-induced microvascular dysfunction in the hydronephrotic kidney: Role of nitric oxide
Vriese, A. S. D., Stoenoiu, M. S., Elger, M., Devuyst, O., Vanholder, R. C., Kriz, W., & Lameire, N. H. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00787.x · Cited by 74
“Impaired responses to different endothelium-dependent agonists have been demonstrated in various vascular beds, including the renal microcirculation, of different models of diabete”
BackgroundSelf-citationBagg, W. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.11.5491 · Cited by 67
Gaubert, M. L., Sigaudo‐Roussel, D., Tartas, M., Berrut, G., Saumet, J. L., & Fromy, B. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.143750 · Cited by 73
“…pathophysiological states, this back-up mechanism operates to preserve endothelial-dependent vasodilatation, as when the NO pathway is impaired due to hypertension (Kemp et al. 1995; Katusic, 2002; Sofola et al. 2002), hypercholesterolaemia (Kagota et al. 1999) or diabetes (De Vriese et al. 2000).”
BackgroundPoittevin, M., Bonnin, P., Pimpie, C., Rivière, L., Sebrié, C., Dohan, A. J. J., Pocard, M. D., Charriaut‐Marlangue, C., & Kubis, N. (2014) · Diabetes · doi:10.2337/db14-0759 · Cited by 73
“Although endothelial dysfunction in the cerebral arteries of patients with diabetes is generally accepted (16), there is no modification of eNOS protein level in STZ-induced diabetic rats (17), downregulation in high-fat diet–induced diabetic mice (18), or upregulation in obese diabetic Zucker rats (19).”
Hyperglycemic Conditions Affect Shape and Ca2+ Homeostasis of Mitochondria in Endothelial Cells
Paltauf-Doburzynska, J., Malli, R., & Graier, W. F. (2004) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000139449.64337.1b · Cited by 62
Mokini, Z., Marcovecchio, M. L., & Chiarelli, F. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.11.018 · Cited by 73
Exercise-induced increase in skeletal muscle vasodilatory responses in obese Zucker rats
Xiang, L., Naik, J. S., & Hester, R. L. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00702.2004 · Cited by 72
“Numerous studies have shown an attenuated endothelium-dependent dilation in diabetic patients and animals (10, 20), but the mechanisms responsible for the endothelial dysfunction are unclear.”
BackgroundB-Type Natriuretic Peptide Prevents Acute Hypertrophic Responses in the Diabetic Rat Heart
Rosenkranz, A. C., Hood, S. G., Woods, R. L., Dusting, G. J., & Ritchie, R. H. (2003) · Diabetes · doi:10.2337/diabetes.52.9.2389 · Cited by 72
“Endothelial NO function is often compromised in diabetes (26).”
BackgroundWhat is new in endothelium-derived hyperpolarizing factors?
Campbell, W. B., & Gauthier, K. M. (2002) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200203000-00008 · Cited by 72
Vascular Reactivity Is Affected by Dietary Consumption of Wild Blueberries in the Sprague-Dawley Rat
Kalea, A. Z., Clark, K., Schuschke, D. A., & Klimis‐Zacas, D. J. (2009) · Journal of Medicinal Food · doi:10.1089/jmf.2008.0078 · Cited by 71
Sun, J., Xu, Y., Sun, S., Sun, Y., & Wang, X. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0495-5 · Cited by 71
“The primary target of glucose-induced dysfunction is endothelial cells and they are therefore most susceptible to proliferating signals [19, 20].”
BackgroundWang, C., Mao, C., Lou, Y., Xu, J., Wang, Q., Zhang, Z., Tang, Q., Zhang, X., Xu, H., & Feng, Y. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13434 · Cited by 70
“However, clinical studies have reported reduced numbers of EPCs and impaired endothelial function in diabetic patients [7].”
BackgroundNS309 restores EDHF‐type relaxation in mesenteric small arteries from type 2 diabetic ZDF rats
Brøndum, E., Kold‐Petersen, H., Simonsen, U., & Aalkjær, C. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00525.x · Cited by 69
“The most commonly observed effect in the resistance arteries is a reduced responsiveness to the endotheliumdependent vasodilator acetylcholine (ACh) (De Vriese et al., 2000 and Hermans, 2007).”
BackgroundWitte, K. K., Jacke, K., Stahrenberg, R., Arlt, G., Reitenbach, I., Schilling, L., & Lemmer, B. (2002) · Nitric Oxide · doi:10.1006/niox.2001.0363 · Cited by 69
Prevalence and Prognostic Implications of Pre-Diabetic State in Patients With Heart Failure
Matsue, Y., Suzuki, M., Nakamura, R., Abe, M., Ono, M., Yoshida, S., Seya, M., Iwatsuka, R., Mizukami, A., Setoguchi, M., et al. (2011) · Circulation Journal · doi:10.1253/circj.cj-11-0754 · Cited by 61
The PI3-K/Akt pathway: roles related to alterations in vasomotor responses in diabetic models
Kobayashi, T., Matsumoto, T., & Kamata, K. (2005) · Journal of Smooth Muscle Research · doi:10.1540/jsmr.41.283 · Cited by 68
“…et al., 1989a, b, 1996a,b,c, 1997; Abiru et al., 1990a, b; Miyata et al., 1992a,b; Tomlinson et al., 1992; Poston and Taylor, 1995; Pieper, 1998; De Vriese et al., 2000; Makino et al., 2000, 2002; Matsumoto et al., 2003, 2004; Kobayashi et al., 2004c), and in type II diabetic rats (Sakamoto et…”
BackgroundVascular dysfunction in diabetes: The endothelial progenitor cells as new therapeutic strategy
Georgescu, A. (2011) · World Journal of Diabetes · doi:10.4239/wjd.v2.i6.92 · Cited by 67
Up-regulation of vascular cyclooxygenase-2 in diabetes mellitus.
Bagi, Z. A., Erdei, N., Papp, Z., Edes, I. F., & Koller, Á. (2006) · PubMed · Cited by 67
Kameritsch, P., Singer, M. S., Nuernbergk, C., Ríos, N., Reyes, A. M., Schmidt, K., Kirsch, J., Schneider, H., Müller, S., Pogoda, K., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1921828118 · Cited by 66
Lau, Y. S., Ling, W. C., Murugan, D. D., & Mustafa, M. R. (2014) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000185 · Cited by 66
“Endothelial dysfunction has been demonstrated in both type 1 and type 2 diabetes, which is associated with decreased level of EDRFs after increased destruction by ROS.(54) Glucose oxidation is believed to be a main source of ROS generation in diabetes followed by glycation and protein kinase C activation.”
BackgroundRoles of Oxidants, Nitric Oxide, and Asymmetric Dimethylarginine in Endothelial Function
Siekmeier, R., Grammer, T. B., & März, W. (2008) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248408326488 · Cited by 66
“Cofactors of NO synthesis are tetrahydrobiopterin (BH4) and nicotinamide adenine dinucleotide phosphate (NADPH; Figure 2).32 However, asymmetric dimethylarginine (ADMA) and geranylgeranyl pyrophosphate (an isoprenoid and intermediate of cholesterol biosynthesis) are physiological inhibitors of eNOS or its synthesis an…”
BackgroundInfluentialGrowth Factors in Proliferative Diabetic Retinopathy
Khan, Z. A., & Chakrabarti, S. (2003) · Journal of Diabetes Research · doi:10.1155/edr.2003.287 · Cited by 66
Sáez, T., Salsoso, R., Leiva, A., Toledo, F., de Vos, P., Faas, M. M., & Sobrevía, L. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.11.010 · Cited by 66
Xavier, F. E., Davel, A. P., Rossoni, L. V., & Vassallo, D. V. (2002) · Vascular Pharmacology · doi:10.1016/s1537-1891(02)00315-4 · Cited by 66
“In addition, it has been demonstrated that some vascular beds, such as tail, basilar or mesenteric arteries, may present an endothelial dysfunction prior to other vessels such as the aorta (to review, see De Vriese et al., 2000).”
BackgroundVascular Compliance Is Reduced in the Early Stages of Type 1 Diabetes
Romney, J. S., & Lewanczuk, R. Z. (2001) · Diabetes Care · doi:10.2337/diacare.24.12.2102 · Cited by 66
“Treatment with ACE inhibitors is known to affect smooth muscle proliferation and improve endothelium-dependent vasodilatation by stimulating production of nitric oxide (22).”
BackgroundChan, N. N., Vallance, P., & Colhoun, H. M. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000072968.00157.6b · Cited by 61
Lü, T., Wang, X.-L., He, T., Zhou, W., Kaduce, T. L., Katušić, Z. S., Spector, A. A., & Lee, H.-C. (2005) · Diabetes · doi:10.2337/diabetes.54.7.2155 · Cited by 66
“Endothelial dysfunction with altered activities of various endothelium-derived factors plays an integral role in diabetic vasculopathy (3).”
BackgroundWong, W. T., Tian, X. Y., Xu, A., Ng, C. F., Lee, H. K., Chen, Z. Y., Au, C. L., Yao, X., & Huang, Y. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2831 · Cited by 61
“Although the exact mechanisms are only partially understood, endothelial dysfunction plays a critical role in the initiation and progression of diabetic vascular diseases (15).”
VDAC: old protein with new roles in diabetes
Sasaki, K., Donthamsetty, R., Heldak, M., Cho, Y.-E., Scott, B. T., & Makino, A. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00087.2012 · Cited by 62
Trefz, P., Obermeier, J., Lehbrink, R., Schubert, J. K., Miekisch, W., & Fischer, D. (2019) · Scientific Reports · doi:10.1038/s41598-019-52165-x · Cited by 65
Folate and Inflammation – links between folate and features of inflammatory conditions
Jones, P. R., Lucock, M. D., Scarlett, C. J., Veysey, M. J., & Beckett, E. (2019) · Journal of Nutrition & Intermediary Metabolism · doi:10.1016/j.jnim.2019.100104 · Cited by 65
Novel mechanisms of endothelial dysfunction in diabetes
Yang, G., Lucas, R., Caldwell, R. B., Yao, L., Romero, M. J., & Caldwell, R. W. (2010) · Journal of Cardiovascular Disease Research · doi:10.4103/0975-3583.64432 · Cited by 64
“Conditions contributing to diabetic vascular remodeling and dysfunction include the effects of oxidative stress and decreased NO bioavailability.[16-19] NO production by endothelial NOS (eNOS) is critically involved in maintaining the integrity and stability of the vascular endothelium, preventing platelet aggregation…”
BackgroundShi, Y., So, K., Man, R. Y. K., & Vanhoutte, P. M. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707439 · Cited by 64
“Oxidative stress is increased in diabetic patients and animals (De Vriese et al., 2000; Alp et al., 2003; Maritim et al., 2003; Taniguchi et al., 2005).”
BackgroundSelf-citationQuintela, A. M., Jiménez, R., Gómez‐Guzmán, M., Zarzuelo-Romero, M. J., Galindo, P., Sánchez, M., Vargas, F., Cogolludo, A. L., Tamargo, J. L., Pérez‐Vizcaíno, F., et al. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.045 · Cited by 64
“tocin; O2 , superoxide; sure; VCAM-1, vascular cell diabetes by an excess generation of the ROS superoxide (O2 ) which inactivates NO [2].”
BackgroundO-GlcNAcase overexpression reverses coronary endothelial cell dysfunction in type 1 diabetic mice
Makino, A., Dai, A., Han, Y., Youssef, K. D., Wang, W., Donthamsetty, R., Scott, B. T., Wang, H., & DILLMANN, W. H. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00069.2015 · Cited by 64
“ENDOTHELIAL CELLS (ECs) regulate vascular tone and vascular formation under physiological conditions, and endothelial dysfunction plays an important role in the pathogenesis of vascular complications of diabetes (5).”
BackgroundMitochondrial arginase II constrains endothelial NOS-3 activity
Lim, H. K., Lim, H. K., Ryoo, S., Benjo, A., Shuleri, K., Miriel, V. A., Baraban, E. G., Camara, A., Soucy, K. G., Nyhan, D. P., et al. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00700.2007 · Cited by 64
Kanie, N., & Kamata, K. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704659 · Cited by 64
“…with the results of numerous other studies on aortae from STZinduced diabetic rats (Oyama et al., 1986; Kamata et al., 1989; Poston & Taylor, 1995; Pieper, 1998; Kamata & Kobayashi, 1996; Kobayashi & Kamata, 1999a, b; 2001; Kobayashi et al., 2000; De Vriese et al., 2000; Hink et al., 2001).”
BackgroundResultLü, T., Ye, D., He, T., Wang, X.-L., Wang, H.-L., & Lee, H.-C. (2008) · Biophysical Journal · doi:10.1529/biophysj.108.138339 · Cited by 63
Totani, L., Rotondo, S., Lorenzet, R., Tognoni, G., De Berardis, G., Nicolucci, A., & Evangelista, V. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-07-0453 · Cited by 57
“Not only high glucose concentrations per se, but also AGEs, which are increased in diabetic patients, induce a pro-inflammatory phenotype in endothelial cells, including upregulation of adhesive molecules (37, 48).”
BackgroundBiomaterials in Valvular Heart Diseases
Taghizadeh, B., Ghavami, L., Derakhshankhah, H., Zangene, E., Razmi, M., Jaymand, M., Zarrintaj, P., Zarghami, N., Jaafari, M. R., Shahri, M. M., et al. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.529244 · Cited by 62
Srinivasan, D. K., Vijaya, M., Samy, R. P., Dheen, S. T., Minqin, R., Watt, F., Kang, Y. J., Bay, B., & Tay, S. S. W. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.07.008 · Cited by 62
“It allows simultaneous detection of elements from Na onwards in the periodic table, with a sensitivity of about 1 ppm in biological materials such as tissue sections and cells [22].”
BackgroundLobato, N. S., Filgueira, F. P., Akamine, E. H., Davel, A. P., Rossoni, L. V., Tostes, R. C., de Carvalho, M. H. C., & Fortes, Z. B. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.02.006 · Cited by 62
“diabetes [22] and hypertension [23], the current investigation attempted to minimize these confounding factors by using the MSG-induced obesity model.”
MethodXie, Z., Gong, M. C., Su, W., Xie, D., TURK, J. W., & Guo, Z. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.057711 · Cited by 62
Sayyed, S. G., Kumar, A., & Sharma, S. S. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.02.033 · Cited by 62
“Impaired endothelium dependent vasodilatation has been demonstrated in various vascular beds of animal models of diabetes and humans with type 1 and type 2 diabetes (De Vriese et al., 2000; Pieper and Siebeneich, 1997).”
BackgroundMatsumoto, T., Wakabayashi, K., Kobayashi, T., & Kamata, K. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00069.2004 · Cited by 62
“Diabetes mellitus is associated with vascular complications, including an impairment of vascular responsiveness to neurotransmitters in the macro- and microvasculature (10).”
BackgroundCanagliflozin Inhibits Human Endothelial Cell Proliferation and Tube Formation
Behnammanesh, G., Durante, Z. E., Peyton, K. J., Martinez-Lemus, L. A., Brown, S. M., Bender, S. B., & Durante, W. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00362 · Cited by 61
Oxidative Stress-Dependent Coronary Endothelial Dysfunction in Obese Mice
Gámez-Méndez, A. M., Vargas‐Robles, H., Ríos, A., & Escalante, B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138609 · Cited by 61
“It has been widely reported that oxidative stress is implicated in a variety of physiological and pathological processes that include aging, cancer, diabetes, and atherosclerosis [46], and plays an important role in the development of endothelial dysfunction and vascular diseases [20, 47, 48].”
BackgroundKristensen, K. L., Dahl, M., Rasmussen, L. M., & Lindholt, J. S. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.308874 · Cited by 61
Zhang, R., Thor, D., Han, X., Anderson, L. C., & Rahimian, R. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00327.2012 · Cited by 61
Hirata, K., Li, T., Nishida, M., Ito, H., Matsuzaki, M., Kasaoka, S., & Hamano, K. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00547.2002 · Cited by 61
“According to other investigators, diabetic vascular disease is based on endothelial dysfunction pathophysiologically induced by hyperglycemia (7).”
BackgroundMylonas, N., Nikolaou, P., Karakasis, P., Stachteas, P., Fragakis, N., & Andreadou, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137274 · Cited by 60
Matsumoto, T., Kobayashi, T., Wakabayashi, K., & Kamata, K. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00303.2005 · Cited by 60
“Impaired endothelium-dependent relaxations have been reported in various types of blood vessels in several animal models of diabetes (11).”
BackgroundChuter, V., Schaper, N., Hinchliffe, R., Mills, J., Azuma, N., Behrendt, C., Boyko, E. J., Conte, M. S., Humphries, M., Kirksey, L., et al. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3701 · Cited by 47
Xu, Q., Hao, X., Yang, Q., & Si, L. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.08.021 · Cited by 59
Stem cells for heart valve regeneration
Weber, B., Emmert, M. Y., & Hoerstrup, S. P. (2012) · Swiss Medical Weekly · doi:10.4414/smw.2012.13622 · Cited by 59
Weaver, S. R., Rendeiro, C., McGettrick, H. M., Philp, A., & Lucas, S. J. E. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02247-8 · Cited by 59
Riad, A., Du, J., Stiehl, S., Westermann, D., Mohr, Z., Sobirey, M., Doehner, W., Adams, V., Pauschinger, M., Schultheiß, H., et al. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.04.065 · Cited by 59
AHLBORG, G., Shemyakin, A. S., Böhm, F., Gonon, A. T., & Pernow, J. (2007) · Diabetes Care · doi:10.2337/dc06-1978 · Cited by 59
Bagi, Z. A., Tóth, E., Koller, Á., & Kaley, G. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00074.2004 · Cited by 59
Casanello, P. C., Escudero, C., & Sobrevía, L. (2006) · Current Vascular Pharmacology · doi:10.2174/157016107779317198 · Cited by 59
“Gestational diabetes is a syndrome characterized by glucose intolerance, leading to maternal hyperglycaemia, first recognized during pregnancy, which has been associated with abnormal foetal development and perinatal complications, such as macrosomia, neonatal hypoglycaemia, and neurological disorders [10, 24, 59-61].”
BackgroundAljofan, M., & Ding, H. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.21986 · Cited by 58
Çiftel, M., Ertuğ, H., Parlak, M., Akçurin, G., & Kardelen, F. (2013) · Diabetes and Vascular Disease Research · doi:10.1177/1479164113508564 · Cited by 58
Walker, A. E., Henson, G. D., Reihl, K. D., Morgan, R. G., Dobson, P. S., Nielson, E. I., Ling, J., Mecham, R. P., Li, D. Y., Lesniewski, L. A., et al. (2015) · The Journal of Physiology · doi:10.1113/jphysiol.2014.285338 · Cited by 52
Pingali, U., Ali, M. A., Gundagani, S., & Nutalapati, C. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s274378 · Cited by 58
C-peptide improves adenosine-induced myocardial vasodilation in type 1 diabetes patients
Johansson, B., Sundell, J., Ekberg, K., Jonsson, C., Seppänen, M., Raitakari, O. T., Luotolahti, M., Nuutila, P., Wahren, J., & Knuuti, J. M. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00236.2003 · Cited by 58
“Among these, autonomic neuropathy, hyperglycemia, and hyperinsulinemia have been suggested to contribute to the coronary dysfunction (6).”
BackgroundNakazawa, T., Kaneko, Y., Mori, A., Saito, M., Sakamoto, K., Nakahara, T., & Ishii, K. (2006) · Vascular Pharmacology · doi:10.1016/j.vph.2006.09.002 · Cited by 58
Parodí, J., Flores, C. A., Aguayo, C. R., Rudolph, M. I., Casanello, P. C., & Sobrevía, L. (2002) · Circulation Research · doi:10.1161/01.res.0000012582.11979.8b · Cited by 58
Glucose enhances expression of TRPC1 and calcium entry in endothelial cells
Bishara, N. B., & Ding, H. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00699.2009 · Cited by 57
The Endothelium in Diabetic Nephropathy
Advani, A., & Gilbert, R. E. (2012) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.02.006 · Cited by 57
Nogueira, G. B., Punaro, G., Oliveira, C. S., Maciel, F. R., Fernandes, T. D. O., Lima, D. Y., Rodrigues, A. M., Mouro, M. G., Araújo, S., & Higa, E. M. S. (2018) · Nitric Oxide · doi:10.1016/j.niox.2018.05.003 · Cited by 57
Gunnett, C. A., Heistad, D. D., & Faraci, F. M. (2003) · Stroke · doi:10.1161/01.str.0000099123.55171.3f · Cited by 50
Metadata
- Authors
- De Vriese, A. S., Verbeuren, T. J., Van de Voorde, J., Lameire, N. H., & Vanhoutte, P. M.
- Affiliations
- Institut Servier (FR)
- Ghent University (BE)
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2000-07
- Volume
- 130
- Issue
- 5
- Pages
- 963-974
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC1572156
- OpenAlex
- W2007880055
- Cited by
- 1,165
- References
- 114
- Citations by year
- 2026: 9 · 2025: 23 · 2024: 32 · 2023: 15 · 2022: 31 · 2021: 27 · 2020: 44 · 2019: 39 · 2018: 41 · 2017: 31 · 2016: 36 · 2015: 50 · 2014: 56 · 2013: 58 · 2012: 62
- FWCI
- 5.41
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- endothelial dysfunction, diabetes mellitus, diabetic vascular disease, endothelium-derived relaxing factor, nitric oxide, prostacyclin, endothelium-derived hyperpolarizing factor, endothelium-dependent vasodilation, protein kinase C, polyol pathway, glycation, oxidative stress, hyperglycemia, ACE inhibitors, folic acid, vascular smooth muscle
- MeSH terms
- Animals, Biological Factors, Diabetes Mellitus, Endothelium, Vascular, Humans, Nitric Oxide, Protein Kinase C, Vasodilation, Signal Transduction, Endothelins, Glycation End Products, Advanced, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.